# Title

 Food and Drugs. PART 810â€”MEDICAL DEVICE RECALL AUTHORITY


# ID

 CFR-2018-title21-vol8.Pt. 810


# Structured Analysis Summary

| Type        | Values                                                                                 |
|:------------|:---------------------------------------------------------------------------------------|
| Constraints | ['within', 'greater', 'after', 'no later than']                                        |
| Duration    | ['2.0 day']                                                                            |
| Condition   | ['where', 'unless', 'subject to', 'when', 'if']                                        |
| Entities    | ['Serious', 'Public', 'Scope', 'Such', 'Food', 'Unique', 'Written', 'Health', 'Cease'] |
| Date        | ['2018-05-13']                                                                         |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                              |
|:--------------|:---------------------------------------------------------------------------------------------------------------------|
| within        | (i) The lot or batch  within which a device was manufactured; (ii) The serial                                        |
| after         | (a) If,  after providing the appropriate person with an opportunity to                                               |
| within        | health professionals and device user facilities be completed within  a specified timeframe.                          |
| within        | have been notified, names of specific individuals contacted within device user facilities, and the dates of such     |
| within        | to the agency employee identified in the order within  the timeframe specified by FDA.                               |
| after         | will not be fewer than 3 working days after  receipt of the cease distribution and notification order.               |
| after         | As provided in &#167;&#8201;16.26(b),  after the hearing commences, the presiding officer may issue                  |
| within        | notification order does not request a regulatory hearing within the timeframe specified by FDA in the cease          |
| after         | this section no fewer than 2 working days after receipt of the request for a hearing, under                          |
| no later than | a hearing, under &#167;&#8201;16.24(e) of this chapter, and no later than 10 working days after the date of issuance |
| after         | this section no fewer than 2 working days after receipt of the request for a hearing, under                          |
| within        | order to require a recall of the device within  15 working days of conducting a regulatory hearing.                  |
| within        | in the order and shall submit the request within the timeframe specified in the order, unless FDA                    |
| within        | order to require a recall of the device within 15 working days of receipt of the written                             |
| after         | denies a request for a hearing, or, if after conducting a regulatory hearing under &#167;&#8201;810.11 or completing |
| within        | amend the order to require such a recall within 15 working days of issuance of a cease                               |
| within        | amend the order to require such a recall within 15 working days of issuance of a cease                               |
| within        | amend the order to require such a recall within 15 working days of issuance of a cease                               |
| within        | amend the order to require such a recall within 15 working days of issuance of a cease                               |
| greater       | recalling the device from the facilities presents a greater health risk than the health risk of not                  |
| within        | copy of the proposed strategy to the agency within  the timeframe specified in the order.                            |
| within        | changes to the strategy that it deems necessary within 7 working days of receipt of the proposed                     |
| within        | a cease distribution and notification or recall order within  30 working days of its receipt.                        |


## Duration

| Duration   | Context                                                                                                                                                               |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.0 day    | However, FDA and the person named in the order may agree to a later date or the presiding officer may determine that the hearing should be held in fewer than 2 days. |


## Condition

| Condition   | Context                                                                                                                           |
|:------------|:----------------------------------------------------------------------------------------------------------------------------------|
| subject to  | received, purchased, or used a device that is subject to a cease distribution and notification order or a                         |
| where       | or removal of a device for human use where FDA finds that there is a reasonable probability                                       |
| when        | that identifies one or more of the following when  included on the label of the device:                                           |
| if          | agency may issue a cease distribution and not if ication order requiring the person named in the                                  |
| subject to  | enable accurate and immediate identification of the device subject to the order, including, where known: (i) The brand            |
| where       | of the device subject to the order, including, where known: (i) The brand name of the device;                                     |
| if          | for a hearing, in whole or in part, if he or she determines that no genuine and                                                   |
| if          | actions required by the cease distribution and not if ication order, determining                                                  |
| if          | actions required by the cease distribution and not if ication order, determining                                                  |
| if          | a recall order, including an appropriate recall strategy, if  FDA later orders a recall.                                          |
| if          | person named in a cease distribution and not if ication order for a regulatory hearing is granted,                                |
| if          | may issue a summary decision on any issue if the presiding officer determines that there is no                                    |
| if          | person named in the cease distribution and not if ication order does not request a regulatory hearing                             |
| unless      | request within the timeframe specified in the order, unless FDA and the person named in the order                                 |
| if          | person named in a cease distribution and not if ication order does not request a regulatory hearing                               |
| if          | person named in a cease distribution and not if ication order does not request a regulatory hearing                               |
| if          | person named in a cease distribution and not if ication order does not request a regulatory hearing                               |
| if          | of issuance of a cease distribution and not if ication order                                                                      |
| if          | Recall of a device from device user facilities, if FDA determines that the risk of recalling the                                  |
| unless      | risk of not recalling the device from use, unless the device can be replaced immediately with an                                  |
| subject to  | mandatory recall order provisions for notification to individuals subject to  the risks associated with use of the device.        |
| if          | not recall a device from device user facilities if  FDA not                                                                       |
| subject to  | that the strategy provides for notice to individuals subject to the risks associated with use of the recalled                     |
| if          | may be provided through the individuals' health professionals if FDA determines that such consultation is appropriate and         |
| where       | The agency may conduct additional audit checks  where  appropriate.                                                               |
| if          | However,  if FDA does not provide the person named in                                                                             |
| where       | on what should be done with the device. where                                                                                     |
| subject to  | immediately; (4) Where appropriate, that the device is subject to a mandatory recall order; and (5) Specific instructions         |
| if          | the notice of a cease distribution and not if ication order or mandatory recall order: (1) Is                                     |
| unless      | distribution and notification order or mandatory recall order. unless                                                             |
| when        | order may discontinue the submission of status reports when the agency terminates the order in accordance with                    |
| when        | or a mandatory recall order issued under &#167;&#8201;810.13 when the agency determines that the person named in                  |
| where       | all health professionals, device user facilities, consignees, and, where appropriate, individuals have been notified of the cease |
| when        | notification to the person named in the order when a request for termination of a cease distribution                              |
| when        | The agency will delay public notification of orders  when the agency determines that such notification may cause                  |


## Entities

| Entities   | Context                                                                                                               |
|:-----------|:----------------------------------------------------------------------------------------------------------------------|
| Food       | Food  and Drugs.                                                                                                      |
| Scope      | Scope .                                                                                                               |
| Serious    | (j)  Serious , adverse health consequence means any significant adverse                                               |
| Unique     | (m)  Unique device identifier (UDI) means an identifier that adequately                                               |
| Cease      | Cease  distribution and notification order.                                                                           |
| Food       | in &#167;&#8201;16.60(h) of this chapter, the Commissioner of Food and Drugs or presiding officer may waive, suspend, |
| Food       | in &#167;&#8201;16.60(h) of this chapter, the Commissioner of Food and Drugs or presiding officer may waive, suspend, |
| Food       | in &#167;&#8201;16.60(h) of this chapter, the Commissioner of Food and Drugs or presiding officer may waive, suspend, |
| Written    | Written request for review of cease distribution and notification                                                     |
| Such       | Such person shall address the written request to the                                                                  |
| Food       | of the order, or, if the Commissioner of Food and Drugs or the presiding officer denies a                             |
| Cease      | Cease  distribution and notification or mandatory recall strategy.                                                    |
| Health     | Health professionals, device user facilities, and consignees who receive                                              |
| Cease      | Cease distribution and notification or mandatory recall order status                                                  |
| Public     | Public  notice.                                                                                                       |


## Date

| Date       | Context                                                                                                                                                                                                                                        |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-05-13 | (a) The person named in a cease distribution and notification order issued under &#167;&#8201;810.10 or a mandatory recall order issued under &#167;&#8201;810.13 may request termination of the order by submitting a written request to FDA. |


